Anti-Tuberculosis Drug Use Patterns in Outpatient Pulmonary Tuberculosis Patients at Kediri District Hospital in 2025

Arifani Siswidiasari; Elly Megasari; Prayoga Fery Yuniarto; Tri Doso Sapto Agus Priyono

doi:10.55927/modern.v5i5.73

Authors

Arifani Siswidiasari Pharmacist Professional Study Program, Faculty of Health Sciences, Kadiri University, Kediri
Elly Megasari Pharmacist Professional Study Program, Faculty of Health Sciences, Kadiri University, Kediri
Prayoga Fery Yuniarto Pharmacy Study Program, Faculty of Health Sciences, Kadiri University, Kediri
Tri Doso Sapto Agus Priyono Pharmacy Study Program, Faculty of Health Sciences, Kadiri University, Kediri

DOI:

https://doi.org/10.55927/modern.v5i5.73

Keywords:

Anti-Tuberculosis, Drug Use Patterns, Pulmonary Tuberculosis

Abstract

Transmission of "mycobacterium tuberculosis" occurs via airborne droplet nuclei originating from an individual with active tuberculosis. This study aims to describe the pattern of anti-tuberculosis drug use among outpatients with pulmonary tuberculosis at the Kediri Regency Regional General Hospital (RSUD) in 2025. A descriptive observational study design with a retrospective approach was employed. Consecutive sampling was used to select subjects meeting the inclusion and exclusion criteria. The study population consisted of all patients diagnosed with pulmonary tuberculosis at the hospital, with a sample size of 62 patients; data collection took place between February and March 2026. Data were collected retrospectively using secondary data from patient medical records. A validated observation sheet (checklist) served as the data collection instrument. The collected data were analyzed using descriptive statistics, with all variables presented as frequencies (n) and percentages (%). The results of the study based on the characteristics of the majority were male (33 patients) (53.2%), age 26-35 years (20 patients) (32.3%), high school education (24 patients) (38.7%), and occupation as farmers (13 patients) (21.0%)

References

Arisandi, D., Sugiarti, W., & Islamarida, R. (2023). Karakteristik Penderita Tuberkulosis Paru di Kabupaten Sleman, D.I.Yogyakarta. Jurnal Formil (Forum Ilmiah) KesMas Respati Vol., 8(1), 64–69. http://formilkesmas.respati.ac.id

Azizah, I. (2020). Determinan Lama Waktu Kesembuhan pada Pengobatan Pasien Tuberkulosis Kategori I. HIGEIA JOURNAL OF PUBLIC HEALTH RESEARCH AND DEVELOPMENT, 4(3), 574–583. https://doi.org/https://doi.org/10.15294 /higeia.v4iSpecial%203/ 34565

Bakhtiar, M. I., Wiedyaningsih, C., Yasin, N. M., & Kristina, S. A. (2021). Hubungan Karakteristik, Kepatuhan, dan Outcome Klinis Pasien Tuberkulosis Paru di Puskesmas Kabupaten Bantul. Majalah Farmasetik, 17(2), 256–269. https://doi.org/10.22146/farmaseutik.v17i2.60681

Bayan, U. A.-Q., Prihanto, E. S. D., & Anwar, M. (2022). Karakteristik Pasien Tuberkulosis Resistan Obat di RSUD Dr. H. Chasan Boesoirie. Kieraha Nedical Journal, 4(1), 15–21. https://ejournal.unkhair.ac.id/index.php/kmj

Fauziah, D. W., Mulyani, E., & Yanti, S. (2022). Rationality Evaluation Of Use Anti-Tuberculosis Drugs In One Of Hospital In Bengkulu Period 2021. Jurnal Farmasi Malahayati, 5(2), 203–209.

Inayah, S., & Wahyono, B. (2019). Penanggulangan Tuberkulosis Paru dengan Strategi DOTS. HIGEIA JOURNAL OF PUBLIC HEALTH, 3(2), 223–233. https://doi.org/https://doi.org/10.15294 /higeia/v2i3/25499

Kemenkes, R. (2019). Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/755/2019 Tentang pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis (pp. 1–139).

Kemenkes, R. (2020). Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis.

Kemenkes, R. (2021). Strategi Nasional Penanggulangan Tuberkulosis di Indonesia 2020-2024 (II, pp. 1–223).

Meyrisca, M., Susanti, R., & Nurmainah. (2022). Hubungan Kepatuhan Penggunaan Obat Anti Tuberkulosis Dengan Keberhasilan Pengobatan Pasien Tuberkulosis di Puskesmas Sungai Betung Bengkayang. LUMBUNG FARMASI : Jurnal Ilmu Kefarmasian, 3(2), 277–282.

Nastiti, A. D., & Kurniawan, C. (2020). Hubungan Dukungan Keluarga Dengan Kepatuhan Kontrol Pasien TB Paru. Jurnal Ilmiah Keperawatan Stikes Hang Tuah Surabaya Vol., 15(1), 78–89.

Nasution, E. S. E., Permatasari, J., & Putra, R. Y. (2026). Hubungan Perilaku Kepatuhan Kontrol Terhadap Kepatuhan Minum Obat Pada Pasien Turbekulosis Paru. 10(7), 60–66.

Nopiayanti, G., Falah, M., & Lismayanti, L. (2022). Faktor-Faktor yang Berhubungan dengan Tingkat Kepatuhan Minum Obat pada Penderita TB di Kota Tasikmalaya. 4(1), 243–247.

Nugrahaeni, D. K., & Malik, U. S. (2015). JAnalisis Penyebab Resistensi Obat Anti Tuberkulosis. 11(1), 8–15.

PDPI. (2021). Tuberkulosis Pedoman Diagnosis dan Penatalaksanan di Indonesia. Perhimpunan Dokter Paru Indonesia.

RISKESDAS. (2018). Laporan Nasional Riskesdas 2018, Kementerian Kesehatan RI, Badan Penelitian dan Pengembangan Kesehatan (BALITBANGKES (ed.)). Badan Penelitian Dan Pengembangan Kesehatan.

Rochjana, A. U. H., & Laeman, S. A. (2024). Profil Penggunaan Obat Anti Tuberkulosis Paru di Instalasi Farmasi Rawat Jalan BPJS Rumah Sakit “X” Jakarta Pusat Periode Januari-Desember 2022. 4(4), 398–405.

Simanjuntak, N. H., Pane, G. C., & Gurning, P. P. B. (2023). Analisis Pengaruh Faktor Kepatuhan Kontrol Terhadap Pasien Tuberkulosis Paru Resisten Obat di Kota Medan. Jurnal Ners: Universitas Pahlawan, 7(2), 1857–1862.

Siswidiasari, A., Megasari, E., Priyono, T. D. S. A., & Probosiwi, N. (2026). Rationality of Anti-Tuberculosis Drug ( OAT ) Use in Pulmonary Tuberculosis Patients at Kediri District Hospital in 2025. Indonesian Journal of Contemporary Multidisciplinary Research (MODERN), 5(3), 517–528. https://doi.org/https://doi.org/10.55927/modern.v5i3.46

SKI. (2023). Survei Kesehatan Indonesia (SKI) Tahun 2023.

Tahitoe, A. D., Satriawan, F. A., Diatri, D., & Zuliza, A. A. (2025). Analisis Efektivitas Berbagai Regimen Terapi Terhadap Kesembuhan Tuberkulosis Resisten Obat. PREPOTIF : Jurnal Kesehatan Masyarakat, 9(3), 9643–9649.

Verencia, A., Naftali, Farizi, G. R. Al, & Ovikariani. (2022). The Study Of Anti Tuberculosis Drugs Used In Pulmonary Tuberculosis Patients. Jurnal Surya Medika (JSM), 8(1), 161–167.

WHO. (2022). Global Tuberculosis Report.

Wibowo, A., Burhan, E., & Putra, A. C. (2021). Pola Resistansi Kuman Tuberkulosis dan Regimen Pengobatan Pada Pasien Tuberkulosis Resisten Obat Di Rumah Sakit Pusat Rujukan Respirasi Nasional Persahabatan Jakarta. 5(1), 1–6.